About Us
Inspiring Wisdom, Standing Out from the Crowd
Zhuhai Deer Bioengineering Co., Ltd. is a high-tech enterprise specializing in the R&D, manufacturing, sales, and service of diagnostic products for pathogenic microorganisms. The company maintains an independent R&D laboratory and a wholly owned subsidiary in the United States. Since its establishment in 2003, it has focused on the field of clinical microbiological diagnostics, aiming to develop automated solutions for clinical microbiology testing and providing etiological diagnostic products and services to more than 5,000 medical institutions worldwide.
Dier Bio adheres to independent R&D, holding numerous national invention patents and other proprietary intellectual property rights, and has been recognized as an IP‑strong enterprise and a high‑tech company. Its core product portfolio covers microbial culture, morphological testing, identification, antimicrobial susceptibility testing, and immune‑inflammatory biomarker analysis. Leveraging automation and information‑technology innovations, the company has developed a clinical microbiology testing automation platform comprising time‑of‑flight mass spectrometry for microorganisms, automated blood‑culture subculturing workstations, and fully automated antimicrobial susceptibility systems, dedicated to helping humanity better address the health challenges posed by infections.
Company establishment
Independent intellectual property rights
Partner Medical Institutions
Exporting Countries and Regions
Product Center
News and Information
